Preeclampsia diagnosis and management. Issue 1 (May 2022)

• Record Type: Journal Article
• Authors: Overton, Eve; Tobes, Daniel; Lee, Allison
• Is Part Of: Best practice & research. Volume 36:Issue 1(2022)
• Page Start: 107
• Page End: 121
• Publication Date: 2022-05
• Subjects: preeclampsia -- hypertensive disorders of pregnancy -- eclampsia -- magnesium -- anesthetic management -- thrombocytopenia; Anesthesiology -- Periodicals; Anesthesia -- Periodicals; Anesthesia -- Periodicals; Anesthetics -- Periodicals; Anesthesia; Anesthesiology; Periodicals; 617.9605
• DOI: 10.1016/j.bpa.2022.02.003
• Languages: English
• ISSNs: 1521-6869

Abstract

Abstract : Preeclampsia is a severe manifestation of maternal hypertensive disease affecting 2–8% of pregnancies. The disease places women at risk of women at risk of life-threatening events, including cerebral hemorrhage, pulmonary edema, acute kidney injury, hepatic failure or rupture, disseminated intravascular coagulation, eclampsia, and placental abruption. In addition to the maternal disease burden, increased fetal morbidity and mortality occurs due to iatrogenic preterm delivery, fetal growth restriction, and placental abruption. Magnesium therapy for seizure prophylaxis and blood pressure control to limit cardiovascular and cerebrovascular morbidity are the cornerstone of treatment. Interdisciplinary planning and management are crucial to optimizing patient outcomes.